Login

Kimball-Inspired Metadata Management: A Lecture by Ross Leishman of DWS Ltd | Steve Hocking, Group CEO of DWS Ltd 00:10:00

Share On Facebook Share On Twitter

Steve Hocking is the Group CEO of DWS Ltd

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
AMC Entertainment CEO Adam Aron Discusses the Impact of Media Mergers on the Industry and Box Office | Adam Aron, CEO, AMC Entertainment Holdings Inc.
00:10:00
Modeling Canada's Water Cycle for Climate Adaptation
00:00:00
Akers Biosciences : It’s now all about execution - Ray Akers, co-founder and executive chairman of Akers Biosciences
00:10:00
Michael Harris Discusses Quantitative Investing and Trend Following at Quest Partners
00:10:00
Market Turbulence: Insights from Emin Baghramyan on Low Volatility Investing | Lead Portfolio Manager, TD Asset Management
00:10:00
Tamago CEO Highlights Strategic Advancements and Undervalued Potential of Polymetallic Project in Northern Quebec
00:10:00
Derrick MacEvie Shares Insights on Stewardship in Finance | Derrick Msibi, CEO , STANLIB Wealth Management.
00:10:00
Livingbridge Announces Strategic Partnership with Gresham House | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
We take an operators approach to investing|Gareth Jones, Managing Partner,FinTech Collective
00:10:00
Sitowise's Year 2023 with CEO Heikki Haasmaa | Heikki Haasma, CEO, Sitowise Group Oyj.
00:10:00
Mike Gianoni Closes bbdevdays 2021 with Gratitude and a Focus on Positive Social Impact | Mike Gianoni, CEO, Blackbaud Inc.
00:10:00
Jim Caron: Fed's Aggressive Rate Cut Signals Potential Market Upside in 2025

© 2026 Nehu